Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02682628 · ClinicalTrials.gov registry record · NA
18791 - Sun Protection Factor Assay
A NA study of Sunscreening Agent, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02682628 is a NA study of Sunscreening Agent that has completed, run by Bayer. The registered enrollment target is 10 participants, below the 23-participant average among 7 other Sunscreening Agent trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02682628, a NA study of Sunscreening Agent, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the Sun Protection Factor (SPF) efficacy on human skin.
Conditions Studied
Interventions
- DRUG Coppertone (BAY987517)
Study Locations (1)
New Jersey
- - Union
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02-18 |
| Est. Completion | 2016-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02682628
The ClinicalTrials.gov registry entry for NCT02682628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 23-participant average among 7 other Sunscreening Agent trials with a reported enrollment target (57% lower). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sunscreening Agent appearing as the primary indexed condition, and to 1 intervention - of which Coppertone (BAY987517) is the first listed.
NCT02682628 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT02682628 about?
NCT02682628 is a clinical study titled "18791 - Sun Protection Factor Assay". To evaluate the Sun Protection Factor (SPF) efficacy on human skin.
What is the current status of trial NCT02682628?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-02-18. Estimated completion is 2016-02-22.
What conditions does trial NCT02682628 study?
This clinical trial studies the following conditions: Sunscreening Agent.
What interventions are being tested in trial NCT02682628?
The interventions under investigation include: Coppertone (BAY987517) (DRUG).
Who is sponsoring clinical trial NCT02682628?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02682628 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sunscreening Agent
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
18842 - Sun Protection Factor Assay
COMPLETED · NA
-
Sun Protection Factor Assay
COMPLETED · NA
-
Outdoor-Use Test for Sunscreen Products in Children Ages 3 to 9 Years Old
COMPLETED · NA
-
18841- Sun Protection Factor Assay
COMPLETED · NA
-
Sun Protection Factor Assay
COMPLETED · NA
-
18616 - Sun Protection Factor Assay
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.